J. Miniarikova

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
J. Miniarikova, Jana Miniarikova
Publication record
16 papers · 532 citations · H-index 7

PAPERS

Secreted therapeutics: monitoring durability of microRNA-based gene therapies in the central nervous system
20213 citationsauthor #6
Transfer of Therapeutic miRNAs Within Extracellular Vesicles Secreted from Huntington’s Disease iPSC-derived Neurons (4548)
20204 citationsauthor #2
MicroRNA-based gene therapy for Huntington's disease : Silencing the villain
20190 citationsauthor #1
Targeting RNA-Mediated Toxicity in C9orf72 ALS and/or FTD by RNAi-Based Gene Therapy
201984 citationsauthor #4
Artificial MicroRNAs Targeting C9orf72 Can Reduce Accumulation of Intra-nuclear Transcripts in ALS and FTD Patients
201951 citationsauthor #3
THERAPEUTIC MICRORNAS TARGETING NUCLEAR HUNTINGTIN FOR A DEVELOPMENT OF A PERSONALIZED GENE THERAPY FOR HUNTINGTON’S DISEASE
20190 citationsauthor #1
AAV5-miHTT Gene Therapy Demonstrates Broad Distribution and Strong Human Mutant Huntingtin Lowering in a Huntington’s Disease Minipig Model
2018135 citationsauthor #2
Translation of MicroRNA-Based Huntingtin-Lowering Therapies from Preclinical Studies to the Clinic.
201842 citationsauthor #1
I04 AAV5-MIHTT gene therapy demonstrates broad distribution and strong human mutant huntingtin lowering in a huntington disease minipig model
20180 citationsauthor #3
AAV 5-miHTT gene therapy demonstrates broad distribution and strong human mutant huntingtin lowering in a Huntington disease minipig model
20183 citationsauthor #2
AAV5-miHTT gene therapy demonstrates suppression of mutant huntingtin aggregation and neuronal dysfunction in a rat model of Huntington’s disease
201781 citationsauthor #1
Preclinical Evaluation of a Lentiviral Vector for Huntingtin Silencing
201716 citationsauthor #7
L5 Pre-clinical evaluation of aav5-mihtt gene therapy of huntington’s disease in rodents
20160 citationsauthor #1
Design, Characterization, and Lead Selection of Therapeutic miRNAs Targeting Huntingtin for Development of Gene Therapy for Huntington's Disease
2016113 citationsauthor #1
L4 Sustained and strong HTT silencing by AAV5-miHTT as therapy for huntington’s disease
20160 citationsauthor #2
M01 Rnai-based Gene Therapy Of Huntington’s Disease
20140 citationsauthor #2

TIMELINE

2014 0 citations

2016 113 citations

2017 97 citations

2018 180 citations

2019 135 citations

2020 4 citations

2021 3 citations

J. Miniarikova

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT